02696.HK
Shanghai Henlius Biotech, Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 70.10
+1.52%Forward multiples
Based on analyst estimates
- P/E forward
- 25.76x
- P/E 2026E
- 29.42x
- P/E 2027E
- 32.94x
- P/E 2028E
- 24.73x
- P/S forward
- 2.67x
Trailing multiples
Trailing twelve months
- P/E TTM
- 37.79x
- PEG TTM
- 0.81x
- Price / book
- 7.20x
- Price / sales
- 4.39x
- Price / cash flow
- 61.07x
Enterprise value
- Enterprise value
- HKD 41.6B
- EV / sales
- 4.79x
- EV / EBITDA
- 29.12x
- EV / EBIT
- 39.77x
- Market cap
- HKD 38.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026